Immutep ADR

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Immutep ADR and other ETFs, options, and stocks.

About IMMP

Immutep Ltd. is a clinical stage biotechnology company, which engages in the development of LAG-3 related immunotherapeutic products for cancer and autoimmune diseases. Its products include eftilagimod alfa (IMP321), IMP761, leramilimab (IMP701), and GSK‘781 (IMP731). 

CEO
Marc Voigt
CEOMarc Voigt
Employees
—
Employees—
Headquarters
Sydney, New South Wales (NSW)
HeadquartersSydney, New South Wales (NSW)
Founded
1987
Founded1987
Employees
—
Employees—

IMMP Key Statistics

Market cap
25.80M
Market cap25.80M
Price-Earnings ratio
-0.48
Price-Earnings ratio-0.48
Dividend yield
—
Dividend yield—
Average volume
42.55K
Average volume42.55K
High today
$3.76
High today$3.76
Low today
$3.42
Low today$3.42
Open price
$3.65
Open price$3.65
Volume
14.76K
Volume14.76K
52 Week high
$70.60
52 Week high$70.60
52 Week low
$2.66
52 Week low$2.66

IMMP News

Benzinga 3d
Immutep Reports Encouraging Survival Data From Phase 2 Cancer Trial

Immutep Limited (NASDAQ:IMMP) on Tuesday announced that investigators in its Phase 2 trial observed promising preliminary long-term outcomes for its lead candid...

Immutep Reports Encouraging Survival Data From Phase 2 Cancer Trial

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.